REDWOOD CITY, Calif.--(BUSINESS WIRE)--Aug. 8, 2006--A.P. Pharma, Inc. (Nasdaq:APPA - News), a specialty pharmaceutical company, today reported financial results for the three months ended June 30, 2006. No royalty revenues were recorded for the second quarter of 2006, compared with $1,187,000 in royalty revenues for the second quarter of the prior year, as effective October 1, 2005, A.P. Pharma completed the sale of its interest in royalties on sales of Retin-A Micro® and Carac®. The Company recorded no contract revenues during the second quarter of 2006, compared with $63,000 in the prior-year second quarter.
